Hirundo Biosciences SA
12.2 FTEHirundo Biosciences reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026), with 12.2 full-time equivalents.
The score of Hirundo Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -42 % Headcount (avg FTE) +336 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hirundo Biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 08 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Hirundo Biosciences's financial analysis
- Solvency-16.1%sector median: 20.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hirundo Biosciences
Hirundo Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.855.065
- VAT number
- BE0681855065
- Peppol
- Registered · 0208:0681855065 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Sep 2017
- Registered office
- 4000 Liège
- Size
- Small · 12.2 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Hirundo Biosciences (SA) has been based in Liège since 2017, active in: buying and selling of own real estate. For 2025, it reports revenue of 0 €, a net loss of €13.7m and equity of −548,240 €. With 12.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -16.1%, below the median of its sector (20.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hirundo Biosciences
Companies in the same business, of comparable size and area, outside its group.
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Fondation Charcot-Vaincre la sclérose en plaques Research and experimental development on natural sciences and engineering Schaerbeek · balance sheet €3.16m
- Euro-Multitel Research and experimental development on natural sciences and engineering Mons · balance sheet €5.04m
- Syscade Research and experimental development on natural sciences and engineering Tournai · balance sheet €2.26m
- Clinical Projects International Research and experimental development on natural sciences and engineering Niel · balance sheet €5.13m
- Spray Ventures Research and experimental development on natural sciences and engineering Deinze · balance sheet 27,331 €
- Nexelis Europe Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.65m
- TotalEnergies Petrochemicals Development Feluy Research and experimental development on natural sciences and engineering Seneffe · balance sheet €8.86m
Frequently asked questions about Hirundo Biosciences
What is the revenue of Hirundo Biosciences?
According to the 2025 annual accounts filed with the NBB, the revenue of Hirundo Biosciences amounts to 0 €.
What is the VAT number of Hirundo Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0681855065 for Hirundo Biosciences, if the company is VAT-registered. Its company number (CBE) is 0681.855.065.
Where is the registered office of Hirundo Biosciences?
According to the CBE register, the registered office of Hirundo Biosciences is in 4000 Liège.
What is the equity of Hirundo Biosciences?
At the close of the 2025 financial year, the equity of Hirundo Biosciences amounts to -548,240 €, a solvency of -16.1% of total assets.
How many people work at Hirundo Biosciences?
12.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hirundo Biosciences?
The register lists 4 active mandates at Hirundo Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hirundo Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →